A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Lumin UV System for Use in Nursing Homes, Ambulatory Care and Primary Care for SARS-CoV-2 N95 Re-Use Is Granted 3B Medical Emergency Use

December 4, 2020

Lumin UV system, has received Emergency Use Authorization from the FDA to permit use of the system, on N95 respirators during the COVID-19 pandemic.

Lumin UV system was designed to clean CPAP accessories but is also used as a multi-purpose sanitizer. Today’s announcement by the FDA allows Lumin to be used by healthcare workers employed in nursing homes, long term acute care, ambulatory, primary care, and clinics to allow N95 re-use to stop the spread of COVID-19 and help keep frontline healthcare workers safe.

UVC was first reportedly used for N95 decontamination during the COVID-19 crisis by the University of Nebraska Medical Center. Since then the CDC recognized UVC as a potential means of decontaminating N95 respirators if the proper wavelength and UVC irradiance dose were used. While the FDA has approved other systems for hospital use, the approved systems are complicated, limited to large hospitals, and/or extremely expensive. Lumin is the only N95 decontamination system formally recognized by FDA for killing SARS-CoV-2 that can be purchased for under $300, and with a small enough footprint to be used safely in small offices and clinics, as well as in nursing homes.

Alex Lucio, CEO of 3B Medical, Inc., said, “The COVID-19 global pandemic requires novel approaches and thinking outside the box.  We were starting to get inundated with calls from hospitals and nursing homes asking if Lumin was strong enough to kill SARS-CoV-2. Lumin’s total output in a single 5-minute cycle ranges up to  2,400 mJ/cm2, which studies show is sufficient to kill almost any pathogen, including SARS-CoV-2. A lot of the calls coming into our office are from Fire & Rescue departments, nursing homes, and smaller community hospitals, clinics, and primary care physician offices trying to keep their workers safe.”

He added, “Lumin is likely the only device designed for home use that is powered high enough to repurpose for this use. We are very excited to have our device authorized by FDA for this application”, concluded Lucio.

N95 mask shortages have been widely reported throughout the country, and globally. “Being able to re-use an N95 mask quickly and effortlessly is a game-changer for allowing healthcare workers to remain safe.  Front line healthcare workers are in dire need of an immediate solution to re-use their masks.  Lumin is fast and easy to use and we are glad the device could be re-purposed to meet that need in this crisis,” said Lucio.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy